Assessing Cancer Risk? Here's What the New DNA Test Can Do :

The Invitae test system aims to assess a person's risk of developing certain cancers but is not intended as a cancer screening tool, the FDA says.

Related Keywords

, Public Health Implications , Common Hereditary Cancers Panel Invitae Corp , Drug Administration , Common Hereditary Cancer Panel , Common Hereditary Cancers Panel , Invitae Corp , Test System , Test Can , Test Can T , Genomics , Genomic Medicine , Edicine Genomic , Breast Cancer , Alignant Breast Neoplasm , Cancer , Alignant Neoplasia , Arcinoma , Cancer Risk , Colorectal Cancer , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Ovarian Cancer , Alignant Ovarian Neoplasm , Gastric Cancer , Alignant Stomach Neoplasm , Lobular Cancer , Lobular Carcinoma , Ancer Lobular , Prostate Carcinoma , Alignant Prostate Neo ,